Compare PIII & GXAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIII | GXAI |
|---|---|---|
| Founded | 2015 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.8M | 9.1M |
| IPO Year | N/A | 2022 |
| Metric | PIII | GXAI |
|---|---|---|
| Price | $2.14 | $1.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $16.25 | N/A |
| AVG Volume (30 Days) | 111.2K | ★ 12.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 52.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,027.00 |
| Revenue This Year | N/A | $42,959.35 |
| Revenue Next Year | $14.85 | $100.00 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1473.05 |
| 52 Week Low | $0.15 | $1.00 |
| 52 Week High | $11.30 | $2.96 |
| Indicator | PIII | GXAI |
|---|---|---|
| Relative Strength Index (RSI) | 41.81 | 50.88 |
| Support Level | $1.96 | $1.23 |
| Resistance Level | $2.85 | $1.50 |
| Average True Range (ATR) | 0.33 | 0.27 |
| MACD | 0.08 | -0.01 |
| Stochastic Oscillator | 46.24 | 18.63 |
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.